Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
Revenues | 69.8 | 54.6 | 64.0 | 116.3 | 135.7 | 59.0 |
Revenue growth | 28.0% | -14.7% | -45.0% | -14.3% | 129.8% | |
Cost of goods sold | 58.2 | 48.2 | 48.8 | 81.7 | 87.6 | 38.7 |
Gross profit | 11.6 | 6.4 | 15.2 | 34.5 | 48.1 | 20.3 |
Gross margin | 16.6% | 11.8% | 23.8% | 29.7% | 35.4% | 34.4% |
Sales and marketing | 7.3 | 9.6 | 10.4 | 13.9 | 12.2 | 7.4 |
Research and development | 8.0 | 17.7 | 16.2 | 26.1 | 23.2 | 13.0 |
General and administrative | 9.6 | 10.3 | 9.8 | 15.1 | 7.2 | 6.7 |
EBIT | -13.2 | -31.1 | -21.3 | -20.6 | 5.4 | -6.8 |
EBIT margin | -19.0% | -57.0% | -33.2% | -17.7% | 4.0% | -11.5% |
Pre-tax income | -13.9 | -38.5 | -30.5 | -24.4 | 2.0 | -8.4 |
Income taxes | 0.2 | 0.2 | -0.5 | 1.4 | 0.8 | 0.1 |
Tax rate | | | 1.7% | | 37.1% | |
Net income | -14.1 | -38.6 | -29.9 | -25.8 | -8.9 | 0.0 |
Net margin | -20.2% | -70.8% | -46.8% | -22.2% | -6.5% | 0.0% |
|
Diluted EPS | ($0.49) | ($4.08) | ($6.48) | ($1.39) | ($2.57) | ($14.96) |
Shares outstanding (diluted) | 28.9 | 9.5 | 4.6 | 18.6 | 3.4 | 0.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|